Evidence map›Paper›PMID 34440262›Full record

ArticleBiomedicines2021

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma.

Cheng-Fa Yeh, Ti-Chun Chan, Hung-Lung Ke, Tzu-Ju Chen, Li-Ching Wu, Hsiang-Ying Lee, Yu-Ching Wei, Wen-Jeng Wu, Chien-Feng Li, Wei-Ming Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cheng-Fa YehDivision of General Internal Medicine, Chi Mei Medical Center, Tainan 710, Taiwan.
Ti-Chun ChanDepartment of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan.
Hung-Lung KeDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Tzu-Ju ChenDepartment of Clinical Pathology, Chi Mei Medical Center, Tainan 710, Taiwan.
Li-Ching WuDepartment of Clinical Pathology, Chi Mei Medical Center, Tainan 710, Taiwan.
Hsiang-Ying LeeDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Yu-Ching WeiDepartment of Pathology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Wen-Jeng WuDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
Chien-Feng LiDepartment of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan.
Wei-Ming LiDepartment of Urology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.

Funding

Kaohsiung Medical University Hospital, Taiwan KMUH107-7R58, KMUH108-8M53, KMUH-DK(C)-110006Ministry of Science and Technology, Taiwan MOST109-2314-B-037-110-MY3, MOST110-2321-B-037-002
6 · The paper itself

Abstract

We investigated the association of receptor tyrosine kinase-like orphan receptor 2 (ROR2) expression with clinicopathological features and oncologic outcomes in large urothelial carcinoma (UC) of the upper tract (UTUC) and urinary bladder (UBUC) cohorts. Through transcriptomic profiling of a published dataset (GSE31684), ROR2 was discovered to be the most upregulated gene during UC progression, focusing on the JNK cascade (GO:0007254). Initially, the evaluation of

Indexed as

bladder cancerprognosisROR2survivalupper tract urothelial carcinoma

Identifiers

PMID34440262
PMCPMC8392262

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.